\
&
Contact us
\
&
Contact us
Starts in 1 week from now
LocationOnline
ProgrammesThis matchmaking event connects solution seekers with innovators advancing sustainability and circularity across industries. It is organised by the Enterprise Europe Network and Up2Circ, with support from the European Commission. The event brings together entrepreneurs, startups, SMEs and other organisations from across Europe and beyond.
The programme includes various activities such as an opening session focused on cultural differences in international business, online pitching sessions with innovations aimed at sustainability, and B2B meetings for collaboration on sustainability transitions. The Climate KIC is contributing to the event with specific sessions to enhance the knowledge-sharing experience.
Everything will happen online and you can register via this website. For more information you can contact miss Maaike Van Overmeire of Enterprise Europe Network Flanders via maaike.vanovermeire@vlaio.be
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
